<?xml version="1.0" encoding="UTF-8"?>
<ref id="B144-pharmaceutics-12-00171">
 <label>144.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Cai</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread</article-title>
  <source>Nanoscale Res. Lett.</source>
  <year>2015</year>
  <volume>10</volume>
  <fpage>413</fpage>
  <pub-id pub-id-type="doi">10.1186/s11671-015-1112-z</pub-id>
  <pub-id pub-id-type="pmid">26489856</pub-id>
 </element-citation>
</ref>
